Next Article in Journal
Part 1: The Role of Thyroglobulin Antibodies in Thyroid Cancer Development and Aggressiveness
Previous Article in Journal
Bioactive Natural Products Targeting Androgen Receptor Signaling in Prostate Cancer: A Systematic Review
Previous Article in Special Issue
Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence
 
 
Correction to Cancers 2025, 17(4), 630.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630

by
Philip J. Chang
1,*,
Andrew E. Hendifar
1,
Gillian Gresham
1,
An Ngo-Huang
2,
Paul E. Oberstein
3,
Nathan Parker
4 and
Andrew L. Coveler
5 on behalf of the Precision Promise Consortium
1
Cedars-Sinai Medical Center, Los Angeles, CA 90211, USA
2
MD Anderson Cancer Center, Houston, TX 77030, USA
3
New York University, New York, NY 10012, USA
4
Moffitt Cancer Center, Tampa, FL 33612, USA
5
University of Washington, Seattle, WA 98105, USA
*
Author to whom correspondence should be addressed.
Cancers 2026, 18(5), 789; https://doi.org/10.3390/cancers18050789
Submission received: 25 December 2025 / Accepted: 13 February 2026 / Published: 28 February 2026
(This article belongs to the Special Issue Management of Pancreatic Cancer)
In the original publication [1], the Precision Promise Consortium was not included in the authorship. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Chang, P.J.; Hendifar, A.E.; Gresham, G.; Ngo-Huang, A.; Oberstein, P.E.; Parker, N.; Coveler, A.L. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chang, P.J.; Hendifar, A.E.; Gresham, G.; Ngo-Huang, A.; Oberstein, P.E.; Parker, N.; Coveler, A.L., on behalf of the Precision Promise Consortium. Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630. Cancers 2026, 18, 789. https://doi.org/10.3390/cancers18050789

AMA Style

Chang PJ, Hendifar AE, Gresham G, Ngo-Huang A, Oberstein PE, Parker N, Coveler AL on behalf of the Precision Promise Consortium. Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630. Cancers. 2026; 18(5):789. https://doi.org/10.3390/cancers18050789

Chicago/Turabian Style

Chang, Philip J., Andrew E. Hendifar, Gillian Gresham, An Ngo-Huang, Paul E. Oberstein, Nathan Parker, and Andrew L. Coveler on behalf of the Precision Promise Consortium. 2026. "Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630" Cancers 18, no. 5: 789. https://doi.org/10.3390/cancers18050789

APA Style

Chang, P. J., Hendifar, A. E., Gresham, G., Ngo-Huang, A., Oberstein, P. E., Parker, N., & Coveler, A. L., on behalf of the Precision Promise Consortium. (2026). Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630. Cancers, 18(5), 789. https://doi.org/10.3390/cancers18050789

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop